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ABSTRACT: Patients with serious mental illness may be less likely to achieve functional 
goals than the general population. Assessment of the functional impact of the illness is 
useful to determine severity of illness, evaluate remission, and achieve optimal treatment 
success. The aims of this study are to determine and compare the prevalence of low 
functional status among outpatients with major axis 1 psychiatric disorders, assess the risk 
factors for low functional status, and determine the proportion of the variance in low 
functional status explained by low self-esteem and non-adherence to medication. A 
descriptive cross-sectional study was conducted among 308 outpatients of the psychiatric 
unit of a tertiary hospital. The Global Assessment of Functions (GAF), Morisky 
Medication Adherence Scale (MMAS-8) and the Rosenberg’s Self-esteem Scale were used 
to collect data, which were analyzed using version 20 of SPSS. Level of statistical 
significance was set at 5% (P< 0.05). The overall prevalence of low functional status was 
40.6%. Patients with schizophrenia had the highest prevalence of low functional status 
(53.4%). Educational attainment, employment status, self-esteem, medication adherence, 
and comorbidity had significant association with functional status. Poor medication 
adherence had the largest relative contribution (35.4%) to the variance in functional status, 
while self-esteem had an insignificant relative contribution of 3.4%. An appreciable 
proportion of the patients in this study had low functional status with more schizophrenic 
patients having impairment than patients with mood disorders. Poor medication adherence, 
among other variables, contributes significantly to low functional status. Physicians should 
give as much attention to functional recovery as they give to symptom resolution in the 
management of psychiatric patients. 
 




Functional status is a multidimensional concept that 
encompasses the subject’s ability to perform daily 
activities and to participate in everyday situations 
such as working, studying, living independently, 
having leisure time and keeping relationships1 
while functional impairment refers to limitations 
due to an illness, as people with a disease may not 
carry out certain functions in their daily lives.2 
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Mental disorders, generally, create societal 
problems because they are often associated with 
impairment in the functional capacity of the 
patients.3,4 When disability was added to the public 
health measures as was the case with the disability 
adjusted life years (DALYs), mental disorders 
ranked as high as cardiovascular and respiratory 
diseases, surpassing all malignancies combined or 
HIV.5 The global burden of disease study, using 
DALYs, thus revealed the true magnitude of mental 
health problem due to the disability they produce.6 
Larry and Mauksch,7 in their study among primary 
care population reported that having psychiatric 
disorders was associated with lower functional 
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status and more disability days compared with not 
having mental illness. In particular, major axis 1 
psychiatric disorders often cause significant 
impairment in the functional status of the patients.8 
Depression, bipolar disorders and schizophrenia are 
major axis 1 disorders9 and are the most common.10 
The relationship between depression and functional 
impairment has been demonstrated in some 
studies.11 A cross sectional survey by Kessler and 
his colleagues3 showed that roughly 60% of 
depressed people reported severe or very severe 
impairment among successfully treated 
respondents. Some patients (20%) indicated 
substantial daily life functional impairment even 
after treatment. 
Bipolar disorder, a chronic incapacitating 
condition, is known to be associated with disability 
and impaired function.12 It accounts for major 
functional impairment worldwide.8 The severity of 
symptoms and fluctuation of mood in patients with 
bipolar disorders are known to impact significantly 
on functioning.13 
Similarly, major functional deficits are found in the 
majority of Schizophrenic subjects and they have 
strong association with low educational levels.14 
Mean functional capacity in patients with 
schizophrenia is reduced by 20% compared to 
general population resulting in overall reduction of 
global functioning.15 
Because functional impairment is a complex 
phenomenon, it is likely to be created by many 
variables, not just by the psychiatric illness.16,17 
Dang and his colleagues,18 noted that mental health 
problems are a major but not the sole contributor to 
functional impairment. This finding seems to be 
supported by the observation that further deficits in 
functioning persist even during remission.11 Thus, 
although functional limitation may reflect the 
effects of underlying psychiatric disorder, other 
variables may compound the effect of the disorder. 
However, most researchers focus on the impact of 
specific psychiatric disorders on functional 
impairment, which is often of primary clinical 
concern to the physician.16,17 Studies have shown 
that psychological variables such as self-esteem 
provide a significant contribution to the amount of 
variance in functional impairment (above that 
explained by demographic and clinical 
variables).16,17 Patients with psychiatric disorders 
often cite decreased self-esteem as significantly 
impairing their lives.19 Previous studies reported a 
relationship between low self-esteem and high 
functional impairment and that self-esteem is 
associated with functional impairment even in 
remitted patients.20 
Poor medication adherence in psychiatric patients 
has been reported to be associated with poor 
psychosocial outcome and poor quality of life.21,22 
Rapoff23 reported that non-adherence in patients 
with chronic diseases can adversely impact their 
social functioning. Zhang and his colleagues24 
similarly reported an association between cost-
related non-adherences to medication and 
limitations in activities of daily living (ADLS) and 
instrumental activities of daily living (IADLS) and 
that non-adherence may worsen functional status. 
Functional capacity is a domain of everyday 
functioning and adequate functional capacity is a 
critical component of recovery from mental illness. 
It is associated with greater engagement in 
community responsibility.25 The ability to perform 
activities of daily living allows the mentally stable 
psychiatric patients, including older patients, to live 
independently in the community. Furthermore, 
achievement of the typical milestone of adulthood 
such as keeping a job, raising a family and 
maintaining a home is strongly dependent on 
adequate functional ability and performance in the 
activities of daily living.26 Therefore, assessing 
patient’s functional status portends important 
clinical relevance; it helps to determine the level of 
severity of the diagnosed disorder,27 track clinical 
progress, evaluate remission and monitor recovery 
after treatment.4 However, because symptoms are 
the most proximal indicators of a disorder, 
researchers, after pharmacological treatment, often 
employ symptoms outcome measures to assess the 
effectiveness of treatment or recovery from illness; 
functional outcome measures are often ignored. A 
meta-analysis of over 90 depression treatment 
outcomes indicate that less than 5% of the clinical 
trials measure and report functional outcomes.4 A 
literature search revealed that empirical evidence 
on the comparative influence of the major 
psychiatric disorders, self-esteem of individual 
patients, and adherence to medication on functional 
status are scanty especially in Nigeria and Africa. 
Therefore, the aims of this study are to: 
1. Determine and compare the prevalence of low 
functional status among outpatients with major 
axis 1 psychiatric disorders (Schizophrenia, 
Bipolar affective disorders and Depression). 
2. Identify risk factors/independent predictors of 
low functional status. 
3. Assess the proportion of the variance in low 
functional status explained by self-esteem and 




Study location and design 
 
This study was conducted at a tertiary hospital in 
Benin City, Nigeria. The hospital serves as a major 
referral center to many primary and secondary 
hospitals in the entire state, as well as many 
neighboring states. The psychiatric unit of the 
mental health department runs outpatient clinics 
three times in a week. A cross sectional descriptive 
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design was adopted and data were collected 




Participants included consecutive psychiatric 
patients who presented for appointments at the 
outpatient clinics of the hospital over a period of 
six months. Eligibility criteria included are: 
• Being an adult aged 18 years and above. 
• Being diagnosed for depression, bipolar 
disorder or schizophrenia based on DSM-1V 
diagnostic criteria, established over the course 
of at least three clinic visits. 
• Being under regular care at the outpatient 
clinic and receiving psychopharmacological 
therapy directed at their clinical condition for a 
period of, at least, six months. 
• Being considered (after relevant mental state 
examination) mentally stable, enough to 
participate in the study. 
• Expression of willingness to voluntarily 




The following instruments were used to collect data 
from the participants: 
 
The Global Assessment of Functioning (GAF) 
Scale: The GAF assesses global functioning of 
adults in terms of a single rating of overall 
psychological, social, and occupational functions.28 
It is a numeric clinician rated scale used widely and 
regularly by mental health clinicians and physicians 
to measure how much a person’s illness/symptoms 
affect his or her day-to-day life on a scale of 1 to 
100. Rating ranges from 1-10 (persistent danger of 
severely hurting self or others, persistent inability 
to maintain minimal personal hygiene or serious 
suicidal act with clear expectation of death) to 91-
100 (no symptoms, superior functioning in a wide 
range of activities). Scores within the range of 11 
and 90, represent varying levels of symptom 
severity and functionality, with a lower score 
indicating low functioning and vice versa. In this 
study, functional status was dichotomized as ‘Low’ 
or ‘High’ based on the mean score on the GAF 
scale: patients with scores below the mean, and 
those with mean and above scores were considered 
as ‘Low’ or ‘High’, respectively. The instrument as 
well as similar dichotomy/cut off-point has been 
used by previous authors in Nigeria to assess 
functioning in adult patients with psychotic 
disorders.29 
 
Morisky Medication Adherence Scale (MMAS-8): 
An 8-item scale is designed by Morisky et al30 It 
was initially developed to evaluate medication 
adherence in patients with hypertension, but it is 
now widely used in various other patient 
populations. Respondents are to answer “Yes” or 
“No” to each of the first seven items, while the last 
item is a 5-point Likert scale response. The tool 
considers three levels of adherence based on the 
following scores: 0 to <6 (low adherence); 6 to <8 
(medium); 8 (high). However, for the purpose of 
this study the levels of adherence were 
dichotomized based on the following scores, 0 to 
<8 (non-adherence); 8 (adherence). Previous 
authors in Nigeria have used the tool, as well as 
similar dichotomy/cut off score.31 
 
The Rosenberg’s Self-esteem Scale:32 This is a 10–
item self-report Likert-type measure that assesses 
an individual’s overall sense of self-worth or self- 
acceptance. Response options of the scale range 
from ‘strongly disagree’ to ‘strongly agree’.  The 
sum of the ratings assigned to all the items, after a 
reverse scoring of the positively worded items 
gives the global scores which range from 10 to 40 
with higher scores indicating higher self-esteem. 
Rosenberg32 initially found it to have strong 
internal consistency reliability of 0.93.32 In Nigeria, 
Okwaraji and his colleagues33 established a 
Cronback alpha of 0.84 and two week test–retest 
reliability coefficient of 0.76. In this study, self-
esteem was dichotomized as ‘Low’ or ‘High’ based 
on the mean score on the Rosenberg’s scale: 
patients with scores below the mean, and those 
with mean and above scores were considered as 
‘Low’ or ‘High’, respectively. Similar 
dichotomy/cut off-point has been used by previous 
authors in Nigeria.34   
 
A socio-demographic and clinical data collection 
sheet: This is designed by the authors to collect 
information from the participants on their socio-
demographic characteristics such as age, marital 
status and so forth, as well as clinical variables 
such as diagnosis, duration of illness, and so forth.    
Comorbidity was defined as the presence of 
another diagnosed chronic illness, like 
hypertension, diabetes mellitus, arthritis and so 





Prior to the commencement of the study, ethical 
approval was obtained from the research and 
ethical committee of the institution. On each clinic 
day, consecutive potential participants were 
approached, the nature and purpose of the study 
was explained to them, and they were informed of 
their liberty to either participate voluntarily or 
decline participation. They were also told there 
would be no penalty for declining participation, nor 
incentive for participating. Confidentiality was 
assured and verbal informed consent was obtained 
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from willing subjects. Participants who gave verbal 
consent and met the eligibility criteria underwent 
mental state assessment by the authors (consultant 
psychiatrists) to establish their mental fitness to 
participate. The questionnaires were self-
administered except the GAF, which was 
administered and rated by the authors 
(psychiatrists). Information provided by the 
participants was corroborated or, where necessary, 
supplemented by clinical details from subjects’ 
case files. 
 
Data analysis   
 
Completed questionnaires were retrieved and 
coded. SPSS version 21 was used to analyze the 
data. Categorical ranking of some socio-
demographic and clinical variables was done. 
Frequency distribution and percentages were 
computed to describe the categorical variables, and 
Chi-square was performed to test the association of 
functional status with those socio-demographic 
variables, and psychiatric diagnoses. Pearson 
correlation analysis was used to assess the 
relationship between GAF scores and some other 
continuous variables. Analysis of variance 
(ANOVA) with Bonferroni Post-Hoc test was used 
to determine the effect of diagnosis on functional 
status by comparing the mean GAF scores of 
patients with depression, bipolar disorder, and 
schizophrenic. Variables that had significant 
association with functional status in the bivariate 
analyses were simultaneously entered into logistic 
regression model to determine independent 
predictors of low functional status, as well as the 
contribution of low self-esteem and poor 





Socio-demographic characteristics of the 
participants 
 
A total of 308 patients, 181 (58.8%) males and 127 
(41.2%) females participated in the study. Their 
mean age was 37.01+12.22 years. One hundred and 
nineteen (38.6%) were currently married, 163 
(53.0%) were never married while 26 (8.4%) were 
previously married (separated, divorced or 
widowed). One hundred and ninety-one (62.0%) 
were currently employed, 117 (38.0%) were 
currently not employed and the average monthly 




The proportion of participants with schizophrenia, 
bipolar disorder and depression were 118 (38.31%), 
107 (34.74%) and 83 (26.95%), respectively. 
Ninety-three (30.2%) participants had comorbid 
illnesses, 141 (46.8%) had low self-esteem, while 
216 (70.1%) were non-adherent to their 
medications. The mean duration of illness was 
7.22±6.34 years and the mean GAF score was 
69.13±10.56. 
             
Prevalence of low functional status 
 
A total of 125 (40.6%) participants had low 
functional status. Schizophrenic patients had the 
highest prevalence of low functional status 
(53.4%), followed by bipolar disorder patients 
(33.6%) while patients with major depression had 
the least at 31.3%. The differences were 
statistically significant (p= 0.061) (Table 1). 
ANOVA test revealed that diagnosis had 
significant effect on functional status (F = 16.251, 
P<0.01), and the Post-Hoc test showed that the 
mean GAF score of patients with schizophrenia 
differed significantly from the mean scores of 
bipolar and depressive disorder patients; the mean 
GAF score of schizophrenic patients was reduced 
by 9.09% and 11.52% compared to that of bipolar 
and depressive disorder patients, respectively. 
There was no significant difference between the 
mean GAF scores of bipolar and depressive 
disorder patients (Table 2). 
 
Correlates of low functional status 
 
Chi-square test showed that the following social-
demographic/clinical variables: age (P = 0.028), 
educational attainment (P = 0.001), employment (P 
= 0.012), self-esteem (P = 0.001), medication 
adherence (P < 0.001), and comorbidity (P < 0.001) 
had significant association with functional status 
(Table 3). 
Pearson correlation revealed that income (r = .157, 
P = 0.001), self-esteem scores (r = .146, P = 0.001), 
and medication adherence scores (r = .413, P< 
0.001) had positive significant relationship with 
GAF scores, while duration of illness (r = -.334, P< 
0.001) and number of previous hospitalization (r = 
.314, P < 0.001) had negative significant 
relationship with GAF scores (Table 4).  
 
Predictors of low functional status 
 
Multiple binary logistic regressions revealed that 
low income, presence of comorbid conditions, poor 
adherence to medication and having schizophrenia 
significantly predicted low functional status while 
controlling for the other variables. The tested 
variables accounted for up to 55.2% of the 
variation in the outcome variable (Table 5). 
Poor medication adherence had the highest relative 
contribution (35.4%) to the variation in functional 
status while self-esteem had an insignificant 
relative contribution of 3.4%. 
Osasona et al / Functional status and its associated factors in Nigerian adults with serious mental illnesses 
	
	
Copyrighted © by Dr. Arun Kumar Agnihotri. All rights reserved | DOI: http://dx.doi.org/10.4314/ijmu.v13i2.3  
 
14 
Table 1: Prevalence of low functional status and its association with psychiatric diagnosis 
 
Psychiatric Diagnosis 
Functional status  
 
Total High Low 
Schizophrenia 55(46.6) 63(53.4)* 118(100.0) 
Bipolar affective disorder 71(66.4) 36(33.6)* 107(100.0) 
Major depression 57(68.7) 26(31.3)* 83(100.0) 
Total 183(59.4) 125(40.6)** 308(100.0) 
 
χ2  = 13.112    df = 2  P = 0.001  
*Specific (diagnosis related) prevalence of low functional status.  
**Overall prevalence of low functional status. 
 
Table 2: Comparison of the mean GAF scores of patients with schizophrenia, bipolar and depressive 
disorders (ANOVA) 
 
GAF scores   
 Sum of Squares Df Mean Square F Sig. 
Between Groups 3296.010 2 1648.005 16.251 .000 
Within Groups 30930.051 305 101.410   
Total 34226.062 307    
 
Bonferroni Post Hoc Tests 


















* 1.344 .000 -9.15 -2.68 
Major depression -7.503* 1.443 .000 -10.98 -4.03 
Bipolar affective 
disorder 
Schizophrenia 5.912* 1.344 .000 2.68 9.15 
Major depression -1.592 1.473 .842 -5.14 1.95 
Major depression 
Schizophrenia 7.503* 1.443 .000 4.03 10.98 
Bipolar affective 
disorder 1.592 1.473 .842 -1.95 5.14 
 
The mean GAF score in schizophrenic patients is reduced by 9.09% and 11.52% in bipolar and depressive 
disorder patients, respectively. 
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Age (years)     
<20 13(76.5) 4(23.5) 10.836 0.028 
20-39 109(61.9) 67(38.1)   
40-59 51(58.6) 36(41.4)   
60 & above 10(33.3) 18(66.7)   
Sex      
Male 105(58.0) 76(42.0) 0.359 0.549 
Female 78(61.4) 49(38.6)   
Marital Status     
Currently married 75(63.0) 44(37.0) 2.558 0.278 
Never married 96(58.9) 67(41.1)   
Previously married 12(46.2) 14(53.8)   
Level of Education     
No formal education 3(21.4) 11(78.6) 17.519 0.001 
Primary education 38(49.4) 39(50.6)   
Secondary education 74(60.7) 48(39.3)   
Tertiary education 68(71.6) 27(28.4)   
Level of Support     
Good support  123(62.8) 73(37.2) 2.493 0.114 
Poor support 60(53.6) 52(46.4)   
Employment status     
Currently employed 124(64.9) 67(35.1) 6.321 0.012 
Not currently employed 59(50.4) 58(49.6)   
Self-esteem      
High 112(68.3) 52(31.7) 11.463 0.001 
Low 71(49.3) 73(50.7)   
Any comorbid illness?     
No 151(70.2) 64(29.8) 34.551 <0.001 
Yes 32(34.4) 61(65.6)   
Medication adherence     
Non-adherence 107(49.5) 109(50.5) 29.265 <0.001 
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Table 4: Correlation matrix of GAF scores with other continuous variable 
 
















** -.334** -.314** .146* .413** 
Sig. (2-tailed)  .010 .000 .000 .010 .000 
Monthly income ($) 
Pearson 
Correlation  1 .057 .047 .106 .096 
Sig. (2-tailed)   .351 .446 .082 .118 
Duration of illness 
Pearson 
Correlation   1 .914
** -.081 -.218** 




Correlation    1 -.067 -.211
** 
Sig. (2-tailed)     .243 .000 
Self- esteem scores 
Pearson 
Correlation     1 .160
** 




Correlation      1 
Sig. (2-tailed)       
 
**Correlation is significant at the 0.01 level (2-tailed) 
*Correlation is significant at the 0.05 level (2-tailed) 
 
Table 5: Predictors of functional status (Multiple logistic regression) 
 
Predictors B Wald Exp(B) 
95% C.I. for EXP(B)  Sig. 
Lower Upper  
Age .010 0.242 1.010 .970 1.053 .623 
Level of Education*   1.788    .618 
No formal education .294 1.112 1.342 .239 7.547 .738 
Primary education .163 .099 1.177 .427 3.244 .753 
Secondary education -.367 .546 .693 .262 1.833 .460 
Monthly Income -.006 9.418 .994 .990 .998 .002 
Currently unemployed** .665 2.239 1.945 .814 4.648 .135 
Duration of illness .039 .268 1.040 .896 1.207 .605 
Hospitalization -.025 .004 .976 .471 2.019 .947 
No comorbidity*** -1.897 16.647 .150 .060 .373 .000 
Medication Adherence score -.785 36.387 .456 .354 .589 .000 
Self Esteem Scores -.064 3.340 .938 .877 1.005 .068 
Diagnosis****  10.437    .005 
Schizophrenia 1.878 9.674 6.539 2.003 21.352 .002 
Bipolar disorder 1.070 3.014 2.915 .871 9.753 .083 
Constant 6.341 12.720 567.583   .000 
 
Reference category for categorical variables: *Tertiary education, **currently employed, ***presence of 
comorbidity, ****Depression    
R2: Coefficient of determination of the logistic model; R2 = 40.2% to 55.2% 
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Prevalence of low functional status 
 
This study examined the prevalence and correlates 
of low functional status among patients attending 
the psychiatric outpatient clinic in Benin City. An 
overall prevalence of 40.6% of low functional 
status was found among patients with serious 
mental illness. This rate falls within the range of 
37.3% - 43.5% previously reported among 
outpatients with schizophrenia and bipolar disorder 
in Nigeria.35 However, higher rates have been 
reported in the United States by Kessler and his 
colleagues3 and Druss et al.36 among patients with 
mental illness using Sheehan Disability Scales. The 
reason for higher rates of low functional status 
among the USA samples is not clear but, generally, 
differences in prevalence rates are related to 
operational definition and measurement of 
impairment, as well as the targeted populations. 
The rate of low functional status found in this study 
is considered high and worrisome considering its 
implication in limiting activities of daily living and 
overall treatment outcome. Therefore, clinicians 
should embrace a more holistic approach in 
management; beyond pharmacotherapy often aimed 
at alleviating symptoms, management should 
include routine assessment of the functional 
capacity of the patients as well as interventions 
targeted at enhancing individual functioning in the 
area of occupation, interpersonal relationships, and 
psychological well-being. 
When the different diagnostic categories 
(schizophrenia, bipolar disorder, and depression) 
were compared, patients with schizophrenia 
reported significantly highest rate (53.4%) of low 
functional status followed by those with bipolar 
disorder (33.6%), while the least prevalence was 
among patients with depression (31.3%). Between 
bipolar and depressive disorder patients, there was 
no significant difference found in their functioning 
status. Numerous studies have reported higher 
disability and functioning among schizophrenic 
compared to mood disorder patients,35,37,38 while 
only a few found no significant difference between 
the two groups.39 A comparable study carried out in 
Nigeria among 200 dyads of psychiatric outpatients 
and their care givers revealed a somewhat similar 
report; higher but non-significant prevalence rate of 
severe impairment in functioning was found among 
the schizophrenic compared to the bipolar disorder 
patients.35 Notable differences between their survey 
and the current one are: their study utilized the 
Social and Occupational Functioning Assessment 
Scale (a scale derived from the Global Assessment 
of Functioning Scale) to evaluate the participants’ 
level of social and occupational functioning40 and a 
cut off-point of 50 from a range of 1 to 100 was 
used to determine those with poor functional status. 
It is understandable why persons with 
schizophrenia will report greater impairment in 
functioning; elements such as cognitive deficits and 
negative symptoms which respond poorly to 
treatment have been strongly linked to functional 
outcome41,42 and these factors are worse in persons 
with schizophrenia. Also, extrapyramidal 
symptoms, as a fall-out of the pharmacological 
agents employed in treatment, may contribute to 
poor functioning.14 Altogether, the clinical picture 
and course of an individual with schizophrenia 
present with a poorer outcome because of the 
severe disability experienced. 
 
Correlates of low functional status 
 
Low functional status was significantly associated 
with psychiatric diagnosis (as discussed above), 
older age, lower educational attainment, lack of 
employment, and presence of co-morbid medical 
illnesses. In addition, functioning scores correlated 
positively with monthly income and medication 
adherence scores, and negatively with duration of 
illness, number of hospitalizations, and self-esteem 
scores. However, following a regression analysis in 
which significant variables on bivariate analysis 
were controlled, low functional status was 
independently predicted by only the presence of 
medical co-morbidities, low monthly income, poor 
medication adherence, and having schizophrenia 
diagnosis. While all the variables investigated 
contributed jointly up to 55.2% of the variance in 
low functional status, medication adherence 
accounted for the highest at 35.4%. 
As shown by this study, the presence of physical 
co-morbidity may influence the outcome of 
functioning In this regard, reports of previous 
studies are mixed: while our finding is in 
agreement with some studies43 it conflicts with 
others.17,44 The influence of comorbid medical 
condition on functioning may vary with the nature 
and severity of the medical condition. For example, 
studies have shown that patients with osteoarthritis 
reported a significantly more functional disability 
than other chronic medical illnesses.45 In this study, 
various medical co-morbidities reported by the 
patients include hypertension, diabetes, 
osteoarthritis, and so forth. Some patients reported 
having more than one condition so, the presence of 
co-morbidity in this study is a mixture of 
conditions. Chronic medical conditions are likely to 
impair the ability to perform a physical task which 
may limit home and work functioning, whereas 
mental disorders are known to impede social 
functioning and relationships.36 The debate 
regarding which of the conditions hamper 
functioning more may depend on which area of 
functioning is in question.46 Nevertheless, the 
combined effect of the two illnesses would be 
interactive. It should be mentioned that physical co-
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morbidity is high among people with mental illness 
but the detection rate is poor.47 The added effect of 
physical ailment on an already disabling mental 
illness will further worsen functioning; therefore, it 
is advisable to treat physical co-morbidities 
adequately in mentally ill persons in order to 
achieve optimal functional outcome.  
Lower income level was also found to be an 
independent risk factor for poor functioning in 
patients with serious mental illness. The reason for 
this is not clear, though lower income has been 
similarly found to predict greater disability in end-
stage renal patients.48 However, when the cross-
sectional nature of the study design is considered, 
low functional status, may be conceived as a 
consequence, rather than a risk, of poor functioning 
among the participants. Functioning, expectedly, 
would impact on employment status, suitability and 
performance; hence, poor functioning will 
invariably lead to lack of employment or lower 
paying job, if the individual is employed. 
The result also shows that poor medication 
adherence predicted low functioning, though the 
relationship between medication adherence and low 
functional status could be explained in both 
directions. It is likely that those with low 
functioning will be less stable mentally, have poor 
insight; and consequently comply less with 
treatment as found in patients with schizophrenia 
and mood disorders.49 It could also be surmised that 
those who comply less with treatment won’t make 
significant clinical improvement resulting 
ultimately in lower functioning. A longitudinal 
study, perhaps in future, might help to determine 
the cause and effect relationship between the two 
variables. 
Self-esteem was a variable of interest investigated 
in this survey because of previous reports which 
link it to poor psycho-social functioning,50 yet, in 
this study, it fell marginally short of statistical 
significance as an independent predictor of low 
functional status. Low self-esteem had a relatively 
insignificant contribution of 3.4% to the variation 
in functional status. The initial correlation (r= .146, 
P= 0.001) that existed with functioning on bivariate 
analysis ceased following regression analysis, and 
this suggests the mediation role of a factor. It is 
probable that one of the independent predictors 
such as medication adherence, known to be 
associated with self-esteem51 contributed to or 
enhanced the effect of self-esteem initially, but the 
moment medication adherence was controlled for, 
the association disappeared. This speculation will 
be of interest to study in the future. 
 
Limitation of study 
The strength of this study is that it compared 
functioning across three important diagnostic 
categories; notwithstanding, there are limitations in 
the study. The method of assessing functioning, 
which is by self-report, is subjective. Both the 
mood state and social desirability bias of 
participants could have influenced rating. An 
objective means of assessing functioning such as 
performance-based assessment or third-party rating 
is advocated in subsequent studies. Similarly, the 
medical co-morbidities were identified by self-
report, however, most of the cases were 
corroborated by information from patients’ case 
files. The relationship between functional status 
and specific medical comorbidity will be a topic of 




Despite the limitations, the findings reveal that 
substantial proportion of persons suffering from 
serious mental illnesses have impaired functional 
status. Schizophrenic patients have more 
impairment in functioning compared with those 
with mood disorders. The contributory effect of 
multiple factors in determining functioning in 
persons with serious mental illness was also 
highlighted. The role of comorbidity and poor 
medication adherence is of clinical significance. 
There is a need to strengthen the multidisciplinary 
approach to the management of mental disorders 
and regularly assess and encourage adherence to 
medication in order to improve the level of 
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